EN

Ширинбек Олими

Город: Москва
Страна: Россия
Дата рождения: 01.07.1977
Место работы: СМ-Клиника, Центр флебологии
Должность: заместитель главного врача по хирургии, руководитель "Центра флебологии"
Рабочий адрес: Москва, Старопетровский проезд д 7а стр 22
Сайт организации: www.smclinic.ru
Мобильный телефон: +7 (926) 430-73-82
Ссылка на резюме: www.smclinic.ru/rezume/olimi-shirinbek/
ORCID: https://orcid.org/0000-0003-2116-2247
Сертификат:
Цианоакрилатная клеевая облитерация варикозных вен в реальной клинической практике: двухлетние результаты лечения

2022

1. Belramman A., Bootun R., Lane T., Davies A. Endovenous Management of Varicose Veins. Angiology. 2018;70(5):388–396. https://doi.org/10.1177/0003319718780049. 2. Robertson L., Evans C., Fowkes F. Epidemiology of chronic venous disease. Phlebology: J Ven Dis. 2008;23(3):103–111. https://doi.org/10.1258/phleb.2007.007061. 3. Yang G., Parapini M., Gagnon J., Chen J. Comparison of cyanoacrylate embolization and radiofrequency ablation for the treatment of varicose veins. Phlebology: J Ven Dis. 2018;34(4): 278–283. https://doi.org/10.1177/0268355518794105. 4. Bootun R., Onida S., Lane T. Varicose veins and their management. Surgery (Oxford). 2016;34(4):165–171. https://doi.org/10.1016/j.mpsur.2016.02.002. 5. Kugler N., Brown K. An update on the currently available nonthermal ablative options in the management of superficial venous disease. J Vasc Surg Venous Lymphat Disord. 2017;5(3):422–429. https://doi.org/10.1016/j.jvsv.2017.01.014. 6. Braithwaite B., Hnatek L., Zierau U., Camci M., Akkersdijk G., Nio D. Radiofrequency-induced thermal therapy: results of a European multicentre study of resistive ablation of incompetent truncal varicose veins. Phlebology: J Ven Dis. 2012;28(1):38–46. https://doi.org/10.1258/phleb.2012.012013. 7. Lurie F., Creton D., Eklof B. Prospective randomised study of Endovenous Radiofrequency Obliteration (Closure) Versus Ligation and Vein Stripping (EVOLVeS): 2-year follow-up. J Vasc Sur. 2005;42(1):178. https://doi.org/10.1016/j.jvs.2005.04.007. 8. Rasmussen L., Lawaetz M., Bjoern L., Vennits B., Blemings A., Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Sur. 2011;98(8):1079–1087. https://doi.org/10.1002/bjs.7555. 9. Cтойко Ю.М., Кириенко А.И., Затевахин И.И., Покровский А.В., Карпенко А.А., Золотухин И.А. и др. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018;(3):188. Режим доступа: https://phlebology-sro.ru/upload/iblock/23d/rossiyskieklinicheskie-rekomendatsii-po-khzv-2018.pdf. Ctoiko Yu.M., Kirienko A.I., Zatevakhin I.I., Pokrovskii A.V., Karpenko A.A., Zolotukhin I.A. et al. Diagnostics and Treatment of Chronic Venous Disease: Guidelines of Russian Phlebological Association. Flebologiya. 2018;(3):188. (In Russ.) Available at: https://phlebology-sro.ru/upload/iblock/23d/rossiyskieklinicheskie-rekomendatsii-po-khzv-2018.pdf. 10. Davies A., Azzam M., Bradbury A., Brookes J., Calam J., Evans D. et al. Varicose veins: diagnosis and management. Clinical guideline [CG168]. Available at: https://www.nice.org.uk/guidance/CG168. 11. Gloviczki P., Dalsing M., Eklöf B., Lurie F., Wakefield T., Monika L., Gloviczki M. (eds.). Handbook of Venous and Lymphatic Disorders. 4th ed. NY: CRC Press; 2017. 815 p. https://doi.org/ 10.1201/9781315382449. 12. Wittens C., Davies A., Bækgaard N., Broholm R., Cavezzi A., Chastanet S. Editor’s Choice – Management of Chronic Venous Disease. Eur J Vas End Sur. 2015;49(6):678–737. https://doi.org/ 10.1016/j.ejvs.2015.02.007. 13. Nesbitt C., Bedenis R., Bhattacharya V., Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Coch Dat Syst Rev. 2014. https://doi.org/10.1002/14651858.cd005624.pub3. 14. Davies H., Popplewell M., Darvall K., Bate G., Bradbury A. A review of randomised controlled trials comparing ultrasoundguided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology: J Ven Dis. 2015;31(4):234–240. https://doi.org/ 10.1177/0268355515595194. 15. Vos C., Ünlü Ç., Bosma J., van Vlijmen C., de Nie A., Schreve M. A systematic review and meta-analysis of two novel techniques of nonthermal endovenous ablation of the great saphenous vein. J Vasc Surg Venous Lymphat Disord. 2017;5(6):880–896. https://doi.org/10.1016/j.jvsv.2017.05.022. 16. Tang T., Rathnaweera H., Kam J., Chong T., Choke E., Tan Y. Endovenous Cyanoacrylate Glue to Treat Varicose Veins and Chronic Venous Insufficiency-Experience Gained From Our First 100+ Truncal Venous Ablations in a Multi-Ethnic Asian Population Using the Medtronic VenaSeal Closure System. J Vasc Surg Venous Lymphat Disord. 2019;7(5):764. https://doi.org/10.1016/j.jvsv.2019.06.007. 17. Labenz J., Börsch G. Successful Endoscopic Hemostasis of Duodenal Variceal Bleeding with Histoacryl. Endoscopy. 1993;25(02):194–194. https://doi.org/10.1055/s-2007-1010287. 18. Teng M., Chen C., Lirng J., Chen S., Lee L., Chang T. N-butyl-2-cyanoacrylate for embolisation of carotid aneurysm. Neuroradiology. 1994;36(2):144–147. https://doi.org/10.1007/bf00588084. 19. Min R., Almeida J., Mclean D., Madsen M., Raabe R. Novel vein closure procedure using a proprietary cyanoacrylate adhesive: 30-day swine model results. Phlebology: J Ven Dis. 2012;27(8): 398–403. https://doi.org/10.1258/phleb.2011.011084. 20. Almeida J., Min R., Raabe R., McLean D., Madsen M. Cyanoacrylate Adhesive for the Closure of Truncal Veins. Vas Endovas Surg. 2011;45(7):631–635. https://doi.org/ 10.1177/1538574411413938. 21. Almeida J., Javier J., Mackay E., Bautista C., Proebstle T. Cyanoacrylate Glue Great Saphenous Vein Ablation: Preliminary 180-Day Follow-Up of a First-In-Man Feasibility Study of a NoCompression-No-Local-Anesthesia Technique. J Vas Sur. 2012;55(1):297. https://doi.org/10.1016/j.jvs.2011.11.008. 22. Lam Y., De Maeseneer M., Lawson J., De Borst G., Boersma D. Expert review on the VenaSeal® system for endovenous cyano-acrylate adhesive ablation of incompetent saphenous trunks in patients with varicose veins. Exp Rev Med Dev. 2017;14(10): 755–762. https://doi.org/10.1080/17434440.2017.1378093. 23. Хартманн К. (ред.). Минимально инвазивное лечение варикозного расширения вен нижних конечностей. М.: ГЭОТАР-Медиа; 2018. 176 с. Khartman K. (ed.). Minimally Invasive Varicose Vein Treatment Moscow: GEOTAR-Media; 2018. 176 p. (In Russ.). 24. Almeida J., Javier J., Mackay E., Bautista C., Proebstle T. First human use of cyanoacrylate adhesive for treatment of sapheАМБУЛАТОРНАЯ ХИРУРГИЯ 2022 19(1):132–139 EXCHANGE OF EXPERIENCE | PRACTICE 139 Вклад авторов: Концепция и дизайн исследования — Ширинбек О. Написание текста — Одинокова С.Н., Мнацаканян Г.В. Сбор и обработка материала — Ширинбек О., Мнацаканян Г.В., Одинокова С.Н. Редактирование — Ширинбек О. Contribution of authors: Study concept and design – Olimi Shirinbek Text development – Gevorg V. Mnatsakanyan, Saniya N. Odinokova Collection and processing of material – Olimi Shirinbek, Gevorg V. Mnatsakanyan, Saniya N. Odinokova Editing – Olimi Shirinbek Информация об авторах: Ширинбек Олими, д.м.н., врач-хирург, заместитель главного врача по хирургии, заведующий кафедрой сердечно-сосудистой хирургии АНО ДПО «Центр медицинского и корпоративного обучения», руководитель Центра флебологии «СМ-Клиника»; 125130, Россия, Москва, Старопетровский проезд, д. 7а, стр. 22; olims@mail.ru Мнацаканян Геворг Вачикович, врач сердечно-сосудистый хирург, Центр флебологии «СМ-Клиника»; 125130, Россия, Москва, Старопетровский проезд, д. 7а, стр. 22; cordestro@yandex.com Одинокова Сания Наилевна, ассистент кафедры анатомии человека, Институт клинической медицины имени Н.В. Склифосовского Первого Московского государственного медицинского университета имени И.М. Сеченова (Сеченовский Университет); 125009, Россия, Москва, ул. Моховая, д. 11, стр. 10; врач-флеболог, ассистент кафедры сердечно-сосудистой хирургии центра медицинского и корпоративного обучения, Центр флебологии «СМ-Клиника»; 125130, Россия, Москва, Старопетровский проезд, д. 7а, стр. 22; saniya_odinokova@mail.ru Information about the authors: Olimi Shirinbek, Dr. Sci. (Med.), Surgeon, Deputy Chief Physician for Surgery, Head of the Cardiovascular Surgery Department at the Center for Medical and Corporate Training, Head of the Surgical Department and the Phlebology Center SM-Clinic; 7a, Bldg. 22, Staropetrovskiy Lane, Moscow, 125130, Russia; olims@mail.ru Gevorg V. Mnatsakanyan, Cardiovascular Surgeon of the Phlebology Center SM-Clinic; 7a, Bldg. 22, Staropetrovskiy Lane, Moscow, 125130, Russia; cordestro@yandex.com Saniya N. Odinokova, Assistant of Human Anatomy Department of Sklifosovsky Institute for Clinical Medicine of Sechenov First Moscow State Medical University (Sechenov University); 11, Bldg. 10, Mokhovaya St., Moscow, 125130, Russia; Phlebologist, Assistant of the Cardiovascular Surgery Department at the Center for Medical and Corporate Training, Phlebology Center SM-Clinic; 7a, Bldg. 22, Staropetrovskiy Lane, Moscow, 125130, Russia; saniya_odinokova@mail.ru nous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2013;1(2):174–180. https://doi.org/10.1016/j.jvsv.2012.09.010. 25. Almeida J., Javier J., Mackay E., Bautista C., Cher D., Proebstle T. Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology: J Ven Dis. 2014;30(6):397–404. https://doi. org/10.1177/0268355514532455. 26. Proebstle T., Alm J., Dimitri S., Rasmussen L., Whiteley M., Lawson J. et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2015;3(1):2–7. https://doi. org/10.1016/j.jvsv.2014.09.001. 27. Proebstle T., Alm J., Dimitri S., Rasmussen L., Whiteley M., Lawson J. et al. Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. https://doi.org/10.1016/j.jvsv.2020.05.019. 28. Morrison N., Gibson K., McEnroe S., Goldman M., King T., Weiss R. et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vas Sur. 2015;61(4):985–994. https://doi. org/10.1016/j.jvs.2014.11.071. 29. Morrison N., Gibson K., Vasquez M., Weiss R., Cher D., Madsen M. et al. VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2017;5(3):321–330. https://doi.org/10.1016/j.jvsv.2016.12.005. 30. Gibson K., Morrison N., Kolluri R., Vasquez M., Weiss R., Cher D. et al. Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2018;6(5):606–613. https://doi.org/10.1016/j.jvsv.2018.04.009. 31. Morrison N., Kolluri R., Vasquez M., Madsen M., Jones A., GibsonK. Comparison of cyanoacrylate closure and radiofrequency ablation for the treatment of incompetent great saphenous veins: 36-Month outcomes of the VeClose randomized controlled trial. Phlebology: J Ven Dis. 2018;34(6):380–390. https://doi.org/ 10.1177/0268355518810259. 32. Morrison N., Gibson K., Vasquez M., Weiss R., Jones A. Fiveyear extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020;8(6):978–989. https://doi.org/10.1016/j.jvsv.2019.12.080. 33. Беленцов С.М. Клеевая технология устранения патологического вено-венозного рефлюкса при хронических заболеваниях вен нижних конечностей: ближайшие и отдаленные результаты. Амбулаторная хирургия. 2021;18(1):48–54. https://doi.org/10.21518/1995-1477-2021-18-1-48-54. Belentsov S.M. VenaSeal for vertical veno-venous reflux elimination in patients with chronic venous disease. Ambulatornaya Khirurgiya. 2021;18(1):48–54. (In Russ.) https://doi.org/ 10.21518/1995-1477-2021-18-1-48-54. 34. Мурзина Е.Л., Лобастов К.В., Барганджия А.Б., Лаберко Л.А., Попов И.Б. Среднесрочные результаты цианоакрилатной эмболизации магистральных подкожных вен. Флебология. 2020;14(4):311 321. https://doi.org/10.17116/ flebo202014041311 Murzina E.L., Lobastov K.V., Bargandzhiya A.B., Laberko L.A., Popov I.B. Mid-Term Results of Cyanoacrylate Embolization of Saphenous Veins. Flebologiya. 2020;14(4):311 321. (In Russ.) https://doi.org/10.17116/flebo202014041311

DOI https://doi.org/10.21518/1995-1477-2022-19-1-132-1 Скачать
Цианоакрилатная клеевая облитерация подкожных вен

2021

См.вложение

DOI " https://doi.org/10.17116/flebo202115041297" Скачать
Фармакотерапия хронических заболеваний вен: возможности cулодексида

2015

1. Коваленко В., Калитко И., Темрезов М., Чемурзиев Р., Петров А. Возможности лечения больных с атеротромботическим поражением артерий нижних конечностей. Врач, 2010, 3: 1-3. 2. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология, 2013, 2: 47. 3. Токмакова А.Ю., Анциферов М.Б., Дедов И.И. Медикаментозная терапия ишемии нижних конечностей у больных сахарным диабетом 2-го типа. Сахарный диабет, 1999, 16: 39-42. 4. Аndreozzi GM, Cordova RM, Scomparin A et al. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region. Int Angiol., 2005, 24(3): 272-7. 5. Andreozzi G.M., Palareti G. Rationale and study design of the SURVET trial (Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis).Pathophysiology of hemostasis and thrombosis. Proceedings for the 21st International Congress on Thrombosis, Milan, July 5-9, 2010; 37:9-10, p.302. 6. Andreozzi GM. Sulodexide in the treatment of chronic venous disease. Am J Cardiovasc Drugs, 2012; doi 10.2165. 7. Bergan JJ, Schmid-Schonbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med, 2006, 3; 355(5):488-98. 8. Capone-Braga M, Tellini L, Boncompagni L, et al. Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations. Clin Ter, 1987, 15; 120 (1):25-31. 9. Carpentier PH, Maricq HR, Biro C, et al. Prevalence, risk factors and clinical patterns of chronic venous disorders of lower limbs. A population-based study in France. J Vasc Surg, 2004, 40: 650-659. 10. Cirujeda LJ, Granado CP. A study on the safety, efficacy, and efficiency of sulodexide compared with acenocumarol in secondary prophylaxis in patients with deep venous thrombosis. Angiology, 2—6, 57(1): 53-64. 11. Ciszewicz M, Polubinska A, Antoniewicz AA et al. Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity. Transl Res, 2009, 153(3): 118-23. 12. Coccheri S, Scondotto G, Agnelli G, Aloisi D et al. Randomised, double-blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thromb Haemost, 2002, 87:947-52. 13. Coccheri S, Scondotto G, Agnelli G, Palazzini E et al. Sulodexide in the treatment of intermittent claudication. Results of a randomised, double-blind, multicentre, placebocontrolled study. European Heart Journal, 2002, 23:1057-1065. 14. Cosmi B, Cini M, Legnani C, et al. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide? A natural mixture of glycosaminoglicans. Thromb Res, 2003, 15, 109 (5-6):333-9. 15. Cospite M, Ferrara F, Cospite V, Palazzini E. Sulodexide and the microcirculatory component in microphlebopathies. Current Medical Research and Opinion, 1992, 13(1): 56-60. 16. Current aspects in chronic venous disease: focus on sulodexide. International Angiology, 2014, 33(3): 209-274. 17. Errichi BM, Cesarone MR, Belcaro G, Marinucci R et al. Prevention of recurrent deep venous thrombosis with sulodexide: The SanVal Registry. Angiology, 2004, 55(3): 243-249. 18. Gaddi A, Galetti C, Illuminati B, Nascetti S. Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease. The Journal of International Medical Research, 1996, 24: 389-406. 19. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg, 2011, 53(5): 2S-48S. 20. Guidelines Italian College of Phlebology Revision 2013. International Angiology, 2013, 32, Suppl.1 to issue No 4, 140p. 21. Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: multicenter crosssectional study in 40 095 patients. Phlebology, 2003, 18: 110-121. 22. Kearon C, Kahn SR, Agnelli G, et al. Antothrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest, 2008, 133(6): 454S-545S. 23. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the «CEAP» classification. Mayo Clin Proc, 1996; 71: 338-345. 24. Kucharzewski M, Franek A, Koziolek H. Treatment of venous leg ulcers with sulodexide. Phlebologie, 2003, 32: 115-20. 25. Lauver DA, Booth EA, White AJ et al. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharmacol Exp Ther, 2005, 312(2): 794-800. 26. Manello F, Raffetto JD. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am J Transl Res, 2011, 3(2): 149-58. 27. Mauro M, Palmieri GC, Palazzini E, et al. Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers: a placebo-controlled study with an enteric-coated formulation. Curr Med Res Opin, 1993, 13(2): 96-108. 28. Messa GL, La Placa G, Puccetti L, et al. Pharmacodynamic effects of sulodexide on profibrinolytic and haemorrheological patterns. Clin Drug Investig, 1995, 10(3): 165-71. 29. Nelson EA, Cullum N, Jones J. Venous leg ulcers. Clin Evid, 2006, 15: 2607-26. 30. Nelson EA, Jones J. Venous leg ulcers. Clin Evid (online), 2008. 31. Nicolaides AN. Chronic venous disease and the leukocyteendothelium interaction: from symptoms to ulceration. Angiology, 2005 Sep-Oct; 56 Suppl.1 S11-9. 32. Ofosu FA. Pharmacological actions of sulodexide. Seminars on thrombosis and hemostasis. 1998, 24(2): 127-138 33. Pannier F, Rabe E. Progression of Chronic Venous Disorders: Results from the Bonn Vein Study. Journal of Vasc Surg, 2001, 53(1): 254-255. 34. Pinto A, Corrao S, Galati D, Arnone S et al. Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs. Angiology. The Journal of Vascular Diseases, 1997, 48(9): 805-811. 35. Rabe E, Pannier F. What have we learned from the Bonn study. Phlebolymphology, 2006, 13(4): 188-193. 36. Saviano M, Maleti O, Liguori L. Double-blind,double-dummy, randomized,multicentre clinical assessment of the efficacy, tolerability, and dose-effect relationship of sulodexide in chronic venous insufficiency. Сurr Med Res Opin, 1993, 13(2): 96-108. 37. Scondotto G, Aloisi D, Ferrari P, et al. Treatment of venous leg ulcers with sulodexide. Angiology, 1999, 50(11): 883-9. 38. Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg, 2000, 14(5): 427-35

Скачать